{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:54:37Z","timestamp":1788447277454,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T00:00:00Z","timestamp":1417564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s10384-014-0365-x","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T14:28:46Z","timestamp":1417530526000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy"],"prefix":"10.1007","volume":"59","author":[{"given":"Tomoaki","family":"Higashiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutaro","family":"Morino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Maegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Ohji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,3]]},"reference":[{"key":"365_CR1","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/014107688407701109","volume":"77","author":"AP Weetman","year":"1984","unstructured":"Weetman AP, McGregor AM, Hall R. Ocular manifestations of Graves\u2019 disease: a review. J R Soc Med. 1984;77:936\u201342.","journal-title":"J R Soc Med"},{"key":"365_CR2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","volume":"329","author":"RS Bahn","year":"1993","unstructured":"Bahn RS, Heufelder AE. Pathogenesis of Graves\u2019 ophthalmopathy. N Engl J Med. 1993;329:1468\u201375.","journal-title":"N Engl J Med"},{"key":"365_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.0.1450107","volume":"145","author":"GJ Kahaly","year":"2001","unstructured":"Kahaly GJ. Imaging in thyroid-associated orbitopathy. Eur J Endocrinol. 2001;145:107\u201318.","journal-title":"Eur J Endocrinol"},{"key":"365_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2249.2002.01792.x","volume":"127","author":"M Ludgate","year":"2002","unstructured":"Ludgate M, Baker G. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol. 2002;127:193\u20138.","journal-title":"Clin Exp Immunol"},{"key":"365_CR5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362:726\u201338.","journal-title":"N Engl J Med"},{"key":"365_CR6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/bmj.1.6160.374","volume":"1","author":"P Dandona","year":"1979","unstructured":"Dandona P, Marshall NJ, Bidey SP, Nathan A, Havard CW. Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J. 1979;1:374\u20136.","journal-title":"Br Med J"},{"key":"365_CR7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7326\/0003-4819-90-6-921","volume":"90","author":"ST Bigos","year":"1979","unstructured":"Bigos ST, Nisula BC, Daniels GH, Eastman RC, Johnston HH, Kohler PO. Cyclophosphamide in the management of advanced Graves\u2019 ophthalmopathy. A preliminary report. Ann Intern Med. 1979;90:921\u20133.","journal-title":"A preliminary report. Ann Intern Med"},{"key":"365_CR8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(83)90514-7","volume":"2","author":"AP Weetman","year":"1983","unstructured":"Weetman AP, McGregor AM, Ludgate M, Beck L, Mills PV, Lazarus JH, et al. Cyclosporin improves Graves\u2019 ophthalmopathy. Lancet. 1983;2:486\u20139.","journal-title":"Lancet"},{"key":"365_CR9","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198911163212002","volume":"321","author":"MF Prummel","year":"1989","unstructured":"Prummel MF, Mourits MP, Berghout A, Krenning EP, van der Gaag R, Koornneef L, et al. Prednisone and cyclosporine in the treatment of severe Graves\u2019 ophthalmopathy. N Engl J Med. 1989;321:1353\u20139.","journal-title":"N Engl J Med"},{"key":"365_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1507\/endocrj.40.63","volume":"40","author":"Y Hiromatsu","year":"1993","unstructured":"Hiromatsu Y, Tanaka K, Sato M, Kuroki T, Nonaka K, Kojima K, et al. Intravenous methylprednisolone pulse therapy for Graves\u2019 ophthalmopathy. Endocr J. 1993;40:63\u201372.","journal-title":"Endocr J"},{"key":"365_CR11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1507\/endocrj.43.689","volume":"43","author":"T Tagami","year":"1996","unstructured":"Tagami T, Tanaka K, Sugawa H, Nakamura H, Miyoshi Y, Mori T, et al. High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy. Endocr J. 1996;43:689\u201399.","journal-title":"Endocr J"},{"key":"365_CR12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1034\/j.1600-0420.2002.800316.x","volume":"80","author":"R Kauppinen-M\u00e4kelin","year":"2002","unstructured":"Kauppinen-M\u00e4kelin R, Karma A, Leinonen E, L\u00f6yttyniemi E, Salonen O, Sane T, et al. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmol Scand. 2002;80:316\u201321.","journal-title":"Acta Ophthalmol Scand"},{"key":"365_CR13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0021-5155(02)00544-0","volume":"46","author":"K Ohtsuka","year":"2002","unstructured":"Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves\u2019 ophthalmopathy. Jpn J Ophthalmol. 2002;46:563\u20137.","journal-title":"Jpn J Ophthalmol"},{"key":"365_CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1742-1241.2006.01004.x","volume":"61","author":"S Aktaran","year":"2007","unstructured":"Aktaran S, Akarsu E, Erba\u011fci I, Araz M, Okumu\u015f S, Kartal M. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves\u2019 ophthalmopathy. Int J Clin Pract. 2007;61:45\u201351.","journal-title":"Int J Clin Pract"},{"key":"365_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/EJE-07-0558","volume":"158","author":"RJ Geest van","year":"2008","unstructured":"van Geest RJ, Sasim IV, Koppeschaar HP, Kalmann R, Stravers SN, Bijlsma WR, et al. Methylprednisolone pulse therapy for patients with moderately severe Graves\u2019 orbitopathy: a prospective, randomized, placebo-controlled study. Eur J Endocrinol. 2008;158:229\u201337.","journal-title":"Eur J Endocrinol"},{"key":"365_CR16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73:639\u201344.","journal-title":"Br J Ophthalmol"},{"key":"365_CR17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, et al. Consensus statement of the European Group on Graves\u2019 Orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158:273\u201385.","journal-title":"Eur J Endocrinol"},{"key":"365_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.410240103","volume":"24","author":"D Eidelberg","year":"1988","unstructured":"Eidelberg D, Newton MR, Johnson G, MacManus DG, McDonald WI, Miller DH, et al. Chronic unilateral optic neuropathy: a magnetic resonance study. Ann Neurol. 1988;24:3\u201311.","journal-title":"Ann Neurol"},{"key":"365_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1212\/WNL.38.2.175","volume":"38","author":"DH Miller","year":"1988","unstructured":"Miller DH, Newton MR, van der Poel JC, du Boulay EP, Halliday AM, Kendall BE, et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology. 1988;38:175\u20139.","journal-title":"Neurology"},{"key":"365_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.52.5.671","volume":"52","author":"AG Kermode","year":"1989","unstructured":"Kermode AG, Moseley IF, Kendall BE, Miller DH, MacManus DG, McDonald WI. Magnetic resonance imaging in Leber\u2019s optic neuropathy. J Neurol Neurosurg Psychiatry. 1989;52:671\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"365_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/thy.1992.2.299","volume":"2","author":"Y Hiromatsu","year":"1992","unstructured":"Hiromatsu Y, Kojima K, Ishisaka N, Tanaka K, Sato M, Nonaka K, et al. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid. 1992;2:299\u2013305.","journal-title":"Thyroid."},{"key":"365_CR22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/eye.1994.126","volume":"8","author":"HB Hoh","year":"1994","unstructured":"Hoh HB, Laitt RD, Wakeley C, Kabala J, Goddard P, Potts MJ, et al. The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease. Eye (Lond). 1994;8:506\u201310.","journal-title":"Eye (Lond)"},{"key":"365_CR23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1259\/0007-1285-67-795-244","volume":"67","author":"RD Laitt","year":"1994","unstructured":"Laitt RD, Hoh B, Wakeley C, Kabala J, Harrad R, Potts M, et al. The value of the short tau inversion recovery sequence in magnetic resonance imaging of thyroid eye disease. Br J Radiol. 1994;67:244\u20137.","journal-title":"Br J Radiol"},{"key":"365_CR24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/eye.1996.140","volume":"10","author":"CC Bailey","year":"1996","unstructured":"Bailey CC, Kabala J, Laitt R, Goddard P, Hoh HB, Potts MJ, et al. Magnetic resonance imaging in thyroid eye disease. Eye (Lond). 1996;10:617\u20139.","journal-title":"Eye (Lond)"},{"key":"365_CR25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/eye.2001.102","volume":"15","author":"E Mayer","year":"2001","unstructured":"Mayer E, Herdman G, Burnett C, Kabala J, Goddard P, Potts MJ. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease. Eye (Lond). 2001;15:313\u20138.","journal-title":"Eye (Lond)"},{"key":"365_CR26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejrad.2005.03.027","volume":"56","author":"EJ Mayer","year":"2005","unstructured":"Mayer EJ, Fox DL, Herdman G, Hsuan J, Kabala J, Goddard P, et al. Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. Eur J Radiol. 2005;56:20\u20134.","journal-title":"Eur J Radiol"},{"key":"365_CR27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.oftal.2011.06.010","volume":"86","author":"N Rodr\u00edguez-Gonz\u00e1lez","year":"2011","unstructured":"Rodr\u00edguez-Gonz\u00e1lez N, P\u00e9rez-Rico C, L\u00f3pez-Para Gim\u00e9nez R, Ar\u00e9valo-Serrano J, Del Amo Garc\u00eda B, Calzada Domingo L, et al. Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves\u2019 orbitopathy. Arch Soc Esp Oftalmol. 2011;86:351\u20137.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"365_CR28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00234-014-1332-4","volume":"56","author":"F Tortora","year":"2014","unstructured":"Tortora F, Prudente M, Cirillo M, Elefante A, Belfiore MP, Romano F. Diagnostic accuracy of short-time inversion recovery sequence in Graves\u2019 Ophthalmopathy before and after prednisone treatment. Neuroradiology. 2014;56:353\u201361.","journal-title":"Neuroradiology"},{"key":"365_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/105072502753600179","volume":"12","author":"N Yokoyama","year":"2002","unstructured":"Yokoyama N, Nagataki S, Uetani M, Ashizawa K, Eguchi K. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Thyroid. 2002;12:223\u20137.","journal-title":"Thyroid"},{"key":"365_CR30","first-page":"168","volume":"21","author":"L Bartalena","year":"2000","unstructured":"Bartalena L, Pinchera A, Marcocci C. Management of Graves\u2019 ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21:168\u201399.","journal-title":"Endocr Rev"},{"key":"365_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000131894","volume":"60","author":"M Gerlach","year":"2008","unstructured":"Gerlach M, Ferbert A. Pure eye muscle involvement in endocrine orbitopathy. Eur Neurol. 2008;60:67\u201372.","journal-title":"Eur Neurol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-014-0365-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-014-0365-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-014-0365-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T02:03:44Z","timestamp":1566093824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-014-0365-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["365"],"URL":"https:\/\/doi.org\/10.1007\/s10384-014-0365-x","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,3]]}}}